Regencell Bioscience Holdings Balance Sheet Health
Financial Health criteria checks 4/6
Regencell Bioscience Holdings has a total shareholder equity of $12.0M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $12.6M and $632.3K respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$11.56m |
| Equity | US$11.99m |
| Total liabilities | US$632.32k |
| Total assets | US$12.62m |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: RGC's short term assets ($11.6M) exceed its short term liabilities ($606.9K).
Long Term Liabilities: RGC's short term assets ($11.6M) exceed its long term liabilities ($25.4K).
Debt to Equity History and Analysis
Debt Level: RGC is debt free.
Reducing Debt: RGC had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Insufficient data to determine if RGC has enough cash runway based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if RGC has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.